Navigation Links
Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device
Date:5/2/2008

Signature P3(TM) Technology Raising the Bar in Motion Preservation

MARQUETTE, Mich., May 2 /PRNewswire/ -- Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the successful human implantation of its next generation cervical total disc replacement (TDR), NuNec Cervical Arthroplasty Device. The surgeries were performed by Drs. Hansen Yuan, Dewei Zou and Wenwen Wu in Beijing China, on patients with degenerative disc disease (DDD) otherwise indicated for standard fusion surgery.

Dr. Yuan, a designing surgeon team member for NuNec said, "This (NuNec) is truly a one-of-a-kind, next generation cervical TDR. It features a unique cam locking mechanism which provides optimum fixation without keel cutting as well as an HA coating on the outer surfaces of the PEEK plates to facilitate consistent biological fixation." Yuan added, "Unlike many cervical disc devices, the radiolucency of the PEEK material in NuNec causes no artifact in MRI or CT imaging."

According to Dr. Zou, an orthopedic surgeon and the President of 306 Hospital, "Our patients are fortunate to be able to benefit from this innovative motion preservation technology. I have used several other cervical TDRs in the past and NuNec is, by far, the easiest to implant. These first patients have expressed immediate pain relief after receiving the NuNec device and I am very pleased with these early results."

Pioneer's signature articulating P3(TM) Technology -- Pioneer PEEK-on-PEEK -- is the heart of the NuNec design. Pioneer will showcase its P3(TM) technology products -- NuBac(TM) Intradiscal Arthroplasty System, NuNec(TM) Cervical Arthroplasty System, and BacJac(TM) Interspinous Decompression System -- at the May 2008 Spine Arthroplasty Society (SAS) meeting in Miami, FL.

Pioneer's CEO and President, Dr. Matthew N. Songer says, "We continue to pioneer the P3 application in our motion preservation products. The established biocompatibility, biodurability, radiolucency, and excellent wear resistance of this technology provide surgeons with the most technologically advanced design in the industry which we believe will lead to reduced operating room times and better patient outcomes."

Earlier this year, Pioneer announced significant findings on the effect of accelerated aging on the wear of PEEK (Poly-ether-ether-ketone). The study, conducted in collaboration with RUSH University in Chicago, determined that wear properties of PEEK-on-PEEK are not susceptible to the effects of accelerated aging. The study bolsters support for the long term durability of the company's P3 designs.

About Pioneer Surgical Technology

Pioneer(R) Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Thoughtful innovation has rewarded the company with over 60 U.S. and Foreign patents with numerous patents pending. The company's comprehensive portfolio of CE or investigational motion preservation devices, vertebral spacers, cervical plating systems, and MIS and Mini-Open Rod systems include notable trade names such as NuBac(TM), BacJac(TM), Contact(TM), IJAK(R), Clarity(TM), SlimFuse(TM), and Quantum(R). Pioneer entered the orthobiologics market with two acquisitions in 2007. Encelle(TM), Inc., developed E-Matrix(TM) for tissue regeneration. Angstrom(TM) Medica, Inc. is the first company to obtain FDA approval for a nanotechnology device - NanOss(TM) - hydroxyapatite bone void filler. The company's three division - Orthopedic, Spinal and Biologic - all work to produce state of the art, cost-effective solutions for surgical procedures that have proven difficult or problematic for both surgeons and patients. Pioneer employs more than 260 people worldwide.


'/>"/>
SOURCE Pioneer Surgical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
2. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
3. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
4. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
5. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
6. Surgical and Trauma Wound Care Market to Tie Up $7 Billion in Sales by 2011
7. Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair
8. Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic
9. Sunnylife Global Announces Completion of Surgical Wing of Xiang Tan World Friendship Hospital
10. STAAR Surgical Receives Approval to Market Visian(R) Toric Implantable Collamer Lens in China
11. Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, ... focused on venture growth investments in biotechnology and ... Josh Richardson , M.D. to Managing Director. ... companies.  He is a board observer at InfaCare ... Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence ...
(Date:2/16/2017)...  ArmaGen, Inc., a privately held biotechnology company ... neurological disorders, today reported preliminary evidence of cognitive ... investigational therapy for the treatment of Hurler and ... or MPS I). The initial results from an ... at the 13 th annual WORLD Symposium ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , February 16, 2017 ... the infusion of innovative telemedicine application, new and ... that are experiencing a boom worldwide. The healthcare ... advancement of technologies, services and new therapies for ... RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
Breaking Biology Technology:
(Date:2/2/2017)... YORK , Feb. 2, 2017  EyeLock LLC, ... released a new white paper " What You Should ... The problem of ensuring user authenticity is a growing ... the authentication of users. However, traditional authentication schemes such ... Biometric authentication offers an elegant solution ...
(Date:1/30/2017)... FRANCISCO , Jan. 30, 2017   Invitae ... the fastest growing genetic information companies, today announced that ... financial results and provide 2017 guidance on Monday, February ... conference call that day at 4:45 p.m. Eastern / ... Invitae,s management team will briefly review financial results, guidance, ...
(Date:1/24/2017)... 2017 Biopharm Reports has carried out ... of nuclear magnetic resonance spectroscopy (NMR). This involved ... current practices, developments, trends and end-user plans over ... and opportunities. These areas include growth in the ... and innovation requirements, hyphenated NMR techniques, main suppliers ...
Breaking Biology News(10 mins):